The greatest unmet needs in biomarker discovery are those discoveries that lead to the
development of clinical diagnostic tests. These clinical diagnostic tests can provide early …

Prostate cancer (PCa) is the second most common cancer in men worldwide. A large
proportion of PCa are latent, never destined to progress or affect the patients' life. It is of …

Cancer is the second most common cause of death in developed countries with
approximately 14 million newly diagnosed individuals and over 6 million cancer‐related …

New markers based on PSA isoforms have recently been developed to improve prostate
cancer (PCa) diagnosis. However, novel approaches are still required to differentiate …

Core fucosylation of N-linked glycoproteins has been linked to the functions of glycoproteins
in physiological and pathological processes. However, quantitative characterization of core …

It is urgently needed to find reliable biofluid biomarkers for early diagnosis of Parkinson's
disease in order to achieve better treatment. Promising biomarkers can be found in …

Prostate cancer is the most common cancer among men in the US and worldwide, and
androgen-deprivation therapy remains the principal treatment for patients. Although a …

Core fucosylation, the attachment of an α-1, 6-linked-fucose to the N-glycan core
pentasaccharide, is an abundant protein modification that plays critical roles in various …

The initial part of this review details the controversy behind the use of a serological level of
prostate-specific antigen (PSA) for the diagnostics of prostate cancer (PCa). Novel …

Esophageal (OC), gastric (GC) and colorectal (CRC) cancers are amongst the digestive
track tumors with higher incidence and mortality due to significant molecular heterogeneity …